What can comparative effectiveness research contribute to integrative health in international perspective?

Claudia M. Witt, Shelly Rafferty Withers, Suzanne Grant, Michael S. Lauer, Sean Tunis, Brian M. Berman

Research output: Contribution to journalArticle

Abstract

The interest in Comparative Effectiveness Research (CER) in the international community is growing. A panel titled "What Can Comparative Effectiveness Research Contribute to Integrative Health in International Perspective?" took place at the 3rd International Research Congress on Integrative Medicine and Health in Portland, Oregon, in 2012. The presentations at this panel highlighted different perspectives on CER, including the funders' and the stakeholders' perspectives from the United States, as well as experiences with economic evaluations from Australia and pragmatic trials in Europe. The funders' perspective emphasized the need for innovation and controlling costs in large-scale studies. The stakeholder's perspective stressed the need to gather the input of stakeholders in shaping the framework for more informative, more decision-maker-driven research. Several examples of cost-effectiveness analyses were offered from Australia. The importance of balancing rigor and pragmatism was also discussed in a presentation of the efficacy-effectiveness continuum. A wide-ranging discussion explored additional questions concerning the translation of evidence into practice; the effect of pragmatic trials on funding or policy; evidentiary distinctions between and among pragmatic trials and traditional randomized clinical trials; and the multiple roles of stakeholders, particularly in generating new information and knowledge. The presentations and discussions showed that more development of methods is needed. This includes developments on study design and statistical approaches, as well as methods for stakeholder involvement and mechanisms to bring these results into practice.

Original languageEnglish (US)
Pages (from-to)874-880
Number of pages7
JournalJournal of Alternative and Complementary Medicine
Volume20
Issue number11
DOIs
StatePublished - Nov 1 2014
Externally publishedYes

Fingerprint

Pragmatic Clinical Trials
Comparative Effectiveness Research
Internationality
Cost-Benefit Analysis
Health
Integrative Medicine
Research
Randomized Controlled Trials
Costs and Cost Analysis

ASJC Scopus subject areas

  • Complementary and alternative medicine
  • Medicine(all)

Cite this

What can comparative effectiveness research contribute to integrative health in international perspective? / Witt, Claudia M.; Rafferty Withers, Shelly; Grant, Suzanne; Lauer, Michael S.; Tunis, Sean; Berman, Brian M.

In: Journal of Alternative and Complementary Medicine, Vol. 20, No. 11, 01.11.2014, p. 874-880.

Research output: Contribution to journalArticle

Witt, Claudia M. ; Rafferty Withers, Shelly ; Grant, Suzanne ; Lauer, Michael S. ; Tunis, Sean ; Berman, Brian M. / What can comparative effectiveness research contribute to integrative health in international perspective?. In: Journal of Alternative and Complementary Medicine. 2014 ; Vol. 20, No. 11. pp. 874-880.
@article{21f4936da5ec4ec0acecb59828030024,
title = "What can comparative effectiveness research contribute to integrative health in international perspective?",
abstract = "The interest in Comparative Effectiveness Research (CER) in the international community is growing. A panel titled {"}What Can Comparative Effectiveness Research Contribute to Integrative Health in International Perspective?{"} took place at the 3rd International Research Congress on Integrative Medicine and Health in Portland, Oregon, in 2012. The presentations at this panel highlighted different perspectives on CER, including the funders' and the stakeholders' perspectives from the United States, as well as experiences with economic evaluations from Australia and pragmatic trials in Europe. The funders' perspective emphasized the need for innovation and controlling costs in large-scale studies. The stakeholder's perspective stressed the need to gather the input of stakeholders in shaping the framework for more informative, more decision-maker-driven research. Several examples of cost-effectiveness analyses were offered from Australia. The importance of balancing rigor and pragmatism was also discussed in a presentation of the efficacy-effectiveness continuum. A wide-ranging discussion explored additional questions concerning the translation of evidence into practice; the effect of pragmatic trials on funding or policy; evidentiary distinctions between and among pragmatic trials and traditional randomized clinical trials; and the multiple roles of stakeholders, particularly in generating new information and knowledge. The presentations and discussions showed that more development of methods is needed. This includes developments on study design and statistical approaches, as well as methods for stakeholder involvement and mechanisms to bring these results into practice.",
author = "Witt, {Claudia M.} and {Rafferty Withers}, Shelly and Suzanne Grant and Lauer, {Michael S.} and Sean Tunis and Berman, {Brian M.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1089/acm.2014.0073",
language = "English (US)",
volume = "20",
pages = "874--880",
journal = "Journal of Alternative and Complementary Medicine",
issn = "1075-5535",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - What can comparative effectiveness research contribute to integrative health in international perspective?

AU - Witt, Claudia M.

AU - Rafferty Withers, Shelly

AU - Grant, Suzanne

AU - Lauer, Michael S.

AU - Tunis, Sean

AU - Berman, Brian M.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The interest in Comparative Effectiveness Research (CER) in the international community is growing. A panel titled "What Can Comparative Effectiveness Research Contribute to Integrative Health in International Perspective?" took place at the 3rd International Research Congress on Integrative Medicine and Health in Portland, Oregon, in 2012. The presentations at this panel highlighted different perspectives on CER, including the funders' and the stakeholders' perspectives from the United States, as well as experiences with economic evaluations from Australia and pragmatic trials in Europe. The funders' perspective emphasized the need for innovation and controlling costs in large-scale studies. The stakeholder's perspective stressed the need to gather the input of stakeholders in shaping the framework for more informative, more decision-maker-driven research. Several examples of cost-effectiveness analyses were offered from Australia. The importance of balancing rigor and pragmatism was also discussed in a presentation of the efficacy-effectiveness continuum. A wide-ranging discussion explored additional questions concerning the translation of evidence into practice; the effect of pragmatic trials on funding or policy; evidentiary distinctions between and among pragmatic trials and traditional randomized clinical trials; and the multiple roles of stakeholders, particularly in generating new information and knowledge. The presentations and discussions showed that more development of methods is needed. This includes developments on study design and statistical approaches, as well as methods for stakeholder involvement and mechanisms to bring these results into practice.

AB - The interest in Comparative Effectiveness Research (CER) in the international community is growing. A panel titled "What Can Comparative Effectiveness Research Contribute to Integrative Health in International Perspective?" took place at the 3rd International Research Congress on Integrative Medicine and Health in Portland, Oregon, in 2012. The presentations at this panel highlighted different perspectives on CER, including the funders' and the stakeholders' perspectives from the United States, as well as experiences with economic evaluations from Australia and pragmatic trials in Europe. The funders' perspective emphasized the need for innovation and controlling costs in large-scale studies. The stakeholder's perspective stressed the need to gather the input of stakeholders in shaping the framework for more informative, more decision-maker-driven research. Several examples of cost-effectiveness analyses were offered from Australia. The importance of balancing rigor and pragmatism was also discussed in a presentation of the efficacy-effectiveness continuum. A wide-ranging discussion explored additional questions concerning the translation of evidence into practice; the effect of pragmatic trials on funding or policy; evidentiary distinctions between and among pragmatic trials and traditional randomized clinical trials; and the multiple roles of stakeholders, particularly in generating new information and knowledge. The presentations and discussions showed that more development of methods is needed. This includes developments on study design and statistical approaches, as well as methods for stakeholder involvement and mechanisms to bring these results into practice.

UR - http://www.scopus.com/inward/record.url?scp=84927750803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927750803&partnerID=8YFLogxK

U2 - 10.1089/acm.2014.0073

DO - 10.1089/acm.2014.0073

M3 - Article

C2 - 25372702

AN - SCOPUS:84927750803

VL - 20

SP - 874

EP - 880

JO - Journal of Alternative and Complementary Medicine

JF - Journal of Alternative and Complementary Medicine

SN - 1075-5535

IS - 11

ER -